Clinical Trial Update: Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers [NA]

View source ↗

Summary

A completed clinical trial evaluating the specificity of a recombinant tuberculosis allergen in BCG-vaccinated healthy volunteers; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• recombinant tuberculosis allergen

Snippet

Sponsor: National Medical Research Center of Phthisiopulmonology and Infectious Diseases | Conditions: Tuberculosis | NA | Status: COMPLETED | Results posted: 2023-08-25